GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shockwave Medical Inc (STU:36M) » Definitions » Total Liabilities

Shockwave Medical (STU:36M) Total Liabilities : €820.6 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shockwave Medical Total Liabilities?

Shockwave Medical's Total Liabilities for the quarter that ended in Mar. 2024 was €820.6 Mil.

Shockwave Medical's quarterly Total Liabilities increased from Sep. 2023 (€817.73 Mil) to Dec. 2023 (€823.36 Mil) but then declined from Dec. 2023 (€823.36 Mil) to Mar. 2024 (€820.63 Mil).

Shockwave Medical's annual Total Liabilities increased from Dec. 2021 (€91.91 Mil) to Dec. 2022 (€127.23 Mil) and increased from Dec. 2022 (€127.23 Mil) to Dec. 2023 (€823.36 Mil).


Shockwave Medical Total Liabilities Historical Data

The historical data trend for Shockwave Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shockwave Medical Total Liabilities Chart

Shockwave Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 35.36 38.13 91.91 127.23 823.36

Shockwave Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 198.53 156.63 817.73 823.36 820.63

Shockwave Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shockwave Medical's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=95.556+(703.308+9.933
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+14.564+0)
=823.4

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=1436.538-613.177
=823.4

Shockwave Medical's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=84.947+(711.294+9.779
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+14.611+0)
=820.6

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=1512.247-691.616
=820.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shockwave Medical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shockwave Medical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Shockwave Medical (STU:36M) Business Description

Traded in Other Exchanges
Address
5403 Betsy Ross Drive, Santa Clara, CA, USA, 95054
ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.

Shockwave Medical (STU:36M) Headlines

No Headlines